SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | - | - | - | - | ₹5.87 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUVEN LIFE SCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | ₹5.87 Cr |
How is Deferred Tax Assets / Liabilities of SUVEN LIFE SCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | -100.00 | |
Mar2020 | ₹5.87 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SUVEN LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN LIFE SCIENCES | ₹3,001.1 Cr | 12.1% | 4.8% | 21.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
SUVEN LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN LIFE SCIENCES | 12.1% |
4.8% |
21.2% |
SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses